Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 25, 2026
Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS networkElena Anghileri, Alessia Marcassoli, Veronica Villani, et al.
Future Oncology (London, England)|April 13, 2019
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?Veronica Villani, Alessandra Fabi, Antonio Tanzilli, et al.
Journal of Neuro-Oncology|October 2, 2015
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)Giuseppe Lombardi, Andrea Pace, Francesco Pasqualetti, et al.
Cancers|May 28, 2022
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter StudyMario Caccese, Matteo Simonelli, Veronica Villani, et al.
Breast Cancer Research and Treatment|July 29, 2025
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective studyGuido Maria Giuffrè, Luisa Carbognin, Giovanna Masone Iacobucci, et al.
American Journal of Clinical Oncology|May 22, 2018
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-OncologyFrancesco Pasqualetti, Andrea Pace, Alessandra Gonnelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 18, 2023
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomasAna Belén Díaz Méndez, Andrea Sacconi, Elisa Tremante, et al.
Cancer Letters|February 29, 2024
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective studyEvelina Miele, Elena Anghileri, Chiara Calatozzolo, et al.
Journal of Translational Medicine|October 16, 2023
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-worldPatrizio Giacomini, Fabio Valenti, Matteo Allegretti, et al.
Pageof 9